BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21398516)

  • 21. hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
    Talukdar I; Sen S; Urbano R; Thompson J; Yates JR; Webster NJ
    PLoS One; 2011; 6(11):e27869. PubMed ID: 22132154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperative-binding and splicing-repressive properties of hnRNP A1.
    Okunola HL; Krainer AR
    Mol Cell Biol; 2009 Oct; 29(20):5620-31. PubMed ID: 19667073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IRF-1 regulates alternative mRNA splicing of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in breast epithelial cells generating an immunoreceptor tyrosine-based inhibition motif (ITIM) containing isoform.
    Dery KJ; Kujawski M; Grunert D; Wu X; Ngyuen T; Cheung C; Yim JH; Shively JE
    Mol Cancer; 2014 Mar; 13():64. PubMed ID: 24650050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
    Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
    PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous nuclear ribonucleoproteins A1 and A2 modulate expression of Tid1 isoforms and EGFR signaling in non-small cell lung cancer.
    Chen CY; Jan CI; Pi WC; Wang WL; Yang PC; Wang TH; Karni R; Wang TC
    Oncotarget; 2016 Mar; 7(13):16760-72. PubMed ID: 26919236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.
    Zerbe LK; Pino I; Pio R; Cosper PF; Dwyer-Nield LD; Meyer AM; Port JD; Montuenga LM; Malkinson AM
    Mol Carcinog; 2004 Dec; 41(4):187-96. PubMed ID: 15390079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing.
    Pelisch F; Khauv D; Risso G; Stallings-Mann M; Blaustein M; Quadrana L; Radisky DC; Srebrow A
    J Cell Biochem; 2012 Jul; 113(7):2319-29. PubMed ID: 22345078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.
    Kashima T; Rao N; David CJ; Manley JL
    Hum Mol Genet; 2007 Dec; 16(24):3149-59. PubMed ID: 17884807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
    Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C
    J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HnRNP C, YB-1 and hnRNP L coordinately enhance skipping of human MUSK exon 10 to generate a Wnt-insensitive MuSK isoform.
    Nasrin F; Rahman MA; Masuda A; Ohe K; Takeda J; Ohno K
    Sci Rep; 2014 Oct; 4():6841. PubMed ID: 25354590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. hnRNP L inhibits CD44 V10 exon splicing through interacting with its upstream intron.
    Loh TJ; Cho S; Moon H; Jang HN; Williams DR; Jung DW; Kim IC; Ghigna C; Biamonti G; Zheng X; Shen H
    Biochim Biophys Acta; 2015 Jun; 1849(6):743-50. PubMed ID: 25623890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
    Xu L; Shen J; Jia J; Jia R
    Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: evidence for replacement of the short cytoplasmic domain isoform by glycosylphosphatidylinositol-linked proteins in human leukocytes.
    Singer BB; Scheffrahn I; Heymann R; Sigmundsson K; Kammerer R; Obrink B
    J Immunol; 2002 May; 168(10):5139-46. PubMed ID: 11994468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition.
    Bonomi S; di Matteo A; Buratti E; Cabianca DS; Baralle FE; Ghigna C; Biamonti G
    Nucleic Acids Res; 2013 Oct; 41(18):8665-79. PubMed ID: 23863836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways.
    Matter N; Marx M; Weg-Remers S; Ponta H; Herrlich P; König H
    J Biol Chem; 2000 Nov; 275(45):35353-60. PubMed ID: 10958793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A truncated hnRNP A1 isoform, lacking the RGG-box RNA binding domain, can efficiently regulate HIV-1 splicing and replication.
    Jean-Philippe J; Paz S; Lu ML; Caputi M
    Biochim Biophys Acta; 2014; 1839(4):251-8. PubMed ID: 24530421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
    Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
    Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. hnRNP A1 Regulates Alternative Splicing of Tau Exon 10 by Targeting 3' Splice Sites.
    Liu Y; Kim D; Choi N; Oh J; Ha J; Zhou J; Zheng X; Shen H
    Cells; 2020 Apr; 9(4):. PubMed ID: 32290247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A highly stable duplex structure sequesters the 5' splice site region of hnRNP A1 alternative exon 7B.
    Blanchette M; Chabot B
    RNA; 1997 Apr; 3(4):405-19. PubMed ID: 9085847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism.
    Clower CV; Chatterjee D; Wang Z; Cantley LC; Vander Heiden MG; Krainer AR
    Proc Natl Acad Sci U S A; 2010 Feb; 107(5):1894-9. PubMed ID: 20133837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.